• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
GYN

American Urological Association Guidelines for Recurrent Uncomplicated Urinary Tract Infections in Women

image_pdfFavoriteLoadingFavorite

SUMMARY:

Urinary tract infections (UTIs) are a common condition in women. 60% of women will experience at least one UTI in their lifetime, with a faction of them experiencing recurrent UTIs. Recurrent urinary tract infections are defined by two separate culture proven episodes of symptomatic acute bacterial cystitis within 6 months, or three episodes in one year.

Note: These guidelines do not apply to patients who are pregnant, immunocompromised, those with any abnormalities of the urinary tract, who show signs or symptoms of systemic bacteremia, or those who self-catheterize or have indwelling catheters

Evaluation

  • Document positive urine cultures in prior episodes to establish diagnosis of recurrent UTI
  • Perform complete history and physical, including a pelvic examination
  • If urine specimen is suspected to be contaminated
    • Repeat urine studies, potentially with a catheterized specimen
  • Do not routinely obtain cystoscopy and imaging in the workup of recurrent UTI
  • Perform urinalysis, urine culture, and sensitivity with every symptomatic cystitis episode before starting treatment
  • Self-start treatment while awaiting culture results
    • Can be offered to certain patients with acute episodes after a urine culture has been collected

Asymptomatic Bacteriuria

  • If patient is asymptomatic, urine testing should not be performed
  • Asymptomatic bacteriuria should not be treated

Antibiotic Treatment

  • First line antibiotics: Nitrofurantoin | TMP-SMX | Fosfomycin
    • Use of fluoroquinolones and cephalosporins have been linked to increased antibiotic resistance
  • Antibiotics should be chosen based on local resistance
  • Recurrent UTIs should be treated with as short a duration of antibiotics as possible | Maximum 7 days
  • If urine culture is resistant to oral antibiotics
    • Treat with parental antibiotics for as short a course possible | Maximum 7 days

Prophylaxis

  • Antibiotic prophylaxis to decrease recurrent of future UTIs
    • Reasonable after shared decision making with patient
  • Cranberry prophylaxis can be offered
  • In peri- and post- menopausal women with recurrent UTIs
    • Vaginal estrogen therapy can reduce the risk of future UTIs if no contraindications

Follow Up

  • Test of cure should not be performed if patient is asymptomatic
  • If symptoms persist after treatment with antibiotics, repeat urine cultures should be performed

Learn More – Primary Sources

AUA: Recurrent Uncomplicated Urinary Tract Infections in Women

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All GYN Posts
Next >

Related ObG Topics:

Uncomplicated Cystitis: When to Culture, How to Treat and Recommended Prevention Strategies
Can Drinking More Water Prevent Recurrent Urinary Tract Infections?
Do Cranberries Decrease Risk of UTIs?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site